GSK launches Iodex UltraGel
Signs of progress against the superbugs, but not yet at the scale needed: Study
GSK credits STEER for Horlicks technology after year long IP Battle
US FDA declines to approve GSK drugs division’s long acting HIV injection
Chiron Behring re-launches its rabies vaccine as ‘Chirorab’
After sartans and ranitidine, where will NDMA show up next?
GSK announces tuberculosis vaccine Phase IIb Trial results
GSK to sell two vaccines in $1.1 billion deal to focus on newer treatments
Teva’s UK arm recalls some batches of Ranitidine: Medicines watchdog
Big Pharma to get bigger, but what about patients?
Page 1 of 2
Page 2 of 2